Best Peptides for Anti-Aging and Longevity (2026)
The speculative shelf. This is the category with the most dinner-party energy and the least human data. Longevity peptides target the machinery of aging itself: mitochondria, telomeres, and cellular energy. The idea is sound. The evidence is early.
Which longevity peptide for which goal
The 4 best longevity peptides, ranked
You want the compound with the most research momentum in aging. Endogenous (your body already makes it), metabolic benefits, exercise capacity.
You want strong human trial data. MOTS-c has impressive rodent data but no completed human longevity trial.
Why it ranks 01
It is not an outside molecule. It is something your body already makes, just less of as you age. MOTS-c is a 16-amino acid mitochondrial-derived peptide that regulates metabolic homeostasis. In animal models, it improves insulin sensitivity, enhances exercise capacity, and protects against age-related metabolic dysfunction. Levels decline with age. The research pipeline is the most active in the longevity space right now. Still early-stage, but this is where the smart money in aging research is looking (Lee et al., Cell Metab 2015).
Dosing and side effects
You want the compound with actual FDA approval and clinical trial data. The only one on this page with regulatory clearance for anything.
You want a compound approved specifically for aging. SS-31 is approved for Barth syndrome. The longevity extrapolation is logical but unproven.
Why it ranks 02
SS-31 targets cardiolipin in the inner mitochondrial membrane. Cardiolipin is the lipid that holds the electron transport chain together. When it degrades with age, your mitochondria make less energy and more oxidative waste. SS-31 stabilizes it. The longevity extrapolation: if mitochondrial dysfunction drives aging, then stabilizing mitochondria should slow the process. The logic is sound. The human aging data does not yet exist. But it is the only compound on this page with FDA approval for anything (Szeto, Antioxid Redox Signal 2014).
Dosing and side effects
You want the telomere angle. Short annual cycles (10-20 days). Also stimulates melatonin production, which helps sleep.
You need Western-replicated data. Most research comes from one group in Russia (Vladimir Khavinson, spanning decades).
Why it ranks 03
Epithalon is a lab-made version of something your pineal gland produces. It switches on telomerase, the enzyme that maintains the protective caps on your chromosomes. Telomeres shorten with each cell division. When they get too short, the cell stops dividing or dies. Epithalon's melatonin stimulation is the side benefit people actually notice: improved sleep and circadian rhythm. The science is real. The evidence base is narrow (Khavinson et al., Bull Exp Biol Med 2003).
Dosing and side effects
You want the most human data in this category. SubQ injection bypasses the bioavailability issues with oral NMN and NR supplements.
You want a peptide. NAD+ is a coenzyme. It is here because it is in every longevity conversation and commonly injected alongside peptides.
Why it ranks 04
NAD+ is present in every cell. It powers hundreds of metabolic reactions including DNA repair, energy production, and sirtuin activation. Levels drop roughly 50% between age 40 and 60. SubQ injection is cheaper, more convenient, and the bioavailability debate is settling in its favor over oral NMN and NR supplements. IV clinics dose 250-1000 mg over 2-4 hours, but SubQ avoids the nausea, time commitment, and cost. Whether raising NAD+ levels translates to meaningful longevity benefits is still being studied, but the cellular energy argument is well-supported (Verdin, Science 2015).
Dosing and side effects
Longevity peptide comparison
How do longevity peptides work?
Aging is not one process. It is several, running in parallel. The longevity peptides on this page target three of them.
Mitochondrial decline. Your mitochondria produce the energy your cells run on. They have their own DNA and produce their own signaling molecules (mitochondrial peptides like MOTS-c). As you age, mitochondrial function drops: less energy, more oxidative damage, slower repair. MOTS-c and SS-31 target this pathway directly.
Telomere shortening. Telomeres are the protective caps on your chromosomes. They shorten with each cell division. When they get too short, the cell stops dividing or dies. Epithalon activates telomerase, the enzyme that maintains telomere length. The telomere peptide hypothesis is that slowing this shortening could slow aspects of aging.
NAD+ depletion. NAD+ is the coenzyme that powers hundreds of metabolic reactions in every cell. Levels drop roughly 50% between age 40 and 60. Lower NAD+ means less efficient energy production, weaker DNA repair, and slower cellular maintenance. NAD+ injection supplements what your cells are losing.
These compounds target real mechanisms. But targeting a mechanism and proving it extends human lifespan are different things. No longevity peptide has demonstrated lifespan extension in a controlled human trial. The mechanisms are sound. The evidence is early. That distinction matters.
The honesty section: what we do not know yet
Longevity peptides are the most speculative category on this wiki. The mechanisms are real. Mitochondrial decline, telomere shortening, and NAD+ depletion are all documented features of aging. What we do not have is large-scale human evidence that supplementing these peptides meaningfully extends lifespan or healthspan.
MOTS-c has impressive rodent data but no completed human longevity trial. Epithalon's data is decades old and largely unreplicated outside one research group. SS-31 is FDA-approved for a rare disease, not for aging. NAD+ has the most human data but the longevity-specific outcomes are still being studied.
If you are looking for peptides for aging with the strongest evidence, start with the compounds that have the most human data (SS-31, NAD+). If you are comfortable with early-stage evidence and want to bet on the mechanism, MOTS-c is where the research momentum is.
- Humanin: MOTS-c's sibling. Another mitochondrial-derived peptide that protects against oxidative stress and apoptosis. Neuroprotective effects in Alzheimer's models. Less commercially available.
- Thymosin Alpha 1: The immune aging peptide. Your thymus shrinks with age, degrading immune function. Approved in 30+ countries for hepatitis B. The longevity angle: immune senescence is a major driver of aging-related disease.
- Rapamycin: Not a peptide. Pharmaceutical mTOR inhibitor. Strongest lifespan-extension data in mammals (NIA ITP studies). Shows up in every longevity conversation. Different mechanism (mTOR pathway) than anything else on this page.
What to track: longevity biomarkers
- IGF-1: Growth hormone marker. Track before and during GH-affecting protocols.
- Fasting glucose and HbA1c: Metabolic health. MOTS-c targets insulin sensitivity directly.
- hsCRP: Systemic inflammation marker. Should trend down on anti-inflammatory protocols.
- CBC with differential: Immune cell counts. Relevant if running Thymosin Alpha 1.
- NAD+ levels: Can be tested via blood draw. Baseline before supplementation is useful.
- Telomere length: Testable but expensive. Relevant for Epithalon protocols. Changes are slow.
Test before you start. Test again at 3 months. The numbers tell you more than how you feel.
Longevity peptides are research chemicals. SS-31 is FDA-approved for Barth syndrome but off-label longevity use requires compounding. MOTS-c, Epithalon, and NAD+ are not manufactured under FDA oversight. If you are sourcing any of these, vet your supplier before you inject. Check the Certificate of Analysis (COA): it should include HPLC purity (98%+), mass spec identity confirmation, and come from a named independent lab you can verify.
Who should not use longevity peptides
Frequently asked questions about longevity peptides
A mitochondrial-derived peptide your body naturally produces. It regulates metabolic homeostasis, improves insulin sensitivity, and enhances exercise capacity in animal studies. Levels decline with age. It is the most searched longevity peptide (49,500/mo) and the one generating the most research interest in the aging field. Full MOTS-c profile.
The first FDA-approved mitochondrial drug. SS-31 is the research name. Elamipretide is the generic name. Forzinity is the brand name. It targets cardiolipin in the inner mitochondrial membrane, stabilizing electron transport and reducing oxidative stress. Approved for Barth syndrome. The only compound on this page with FDA approval for anything. Full SS-31 profile.
The telomerase activation mechanism is real. The question is whether a 10-20 day peptide cycle produces meaningful telomere extension in humans. The data says it activates the enzyme. Whether that translates to measurable anti-aging effects is unproven at modern trial standards. Most data comes from Russian research groups led by Vladimir Khavinson. Western replication is limited.
Not technically. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, not a peptide. It shows up on this page because it is in every longevity protocol conversation and is commonly injected subcutaneously alongside peptides. SubQ injection bypasses the bioavailability issues with oral NMN and NR supplements. Whether raising NAD+ levels translates to meaningful longevity benefits is still being studied, but the cellular energy argument is well-supported.
Peptides encoded by mitochondrial DNA rather than nuclear DNA. Your mitochondria have their own genome and produce their own signaling molecules. MOTS-c and humanin are the two most studied. They regulate metabolism, stress response, and cell survival. The field is young. Most data is from animal models. The concept is sound: if mitochondrial decline drives aging, then restoring mitochondrial signals might slow it.
Where to go from here
Also: every question · storage guide · stacking FAQ · something feels off?
Content reviewed against PubMed, ClinicalTrials.gov, and FDA databases. Evidence tiers assigned using the vialprep methodology. Last reviewed September 2026. This content is not medical advice. Talk to a licensed clinician before starting any protocol.